MagVenture announced today that it launched the patent-pending MagVenture Flow Arm for brain stimulation positioning. Alpharetta, Ga.–based MagVenture’s Flow Arm clinical positioning system is designed to optimize the delivery of the company’s FDA-cleared protocols for non-invasive brain stimulation technology in treating major depressive disorder and as an adjunct therapy for OCD, according to a news […]
MagVenture
MagVenture wins FDA clearance for OCD TMS treatment device
MagVenture announced that it received FDA clearance for its TMS Therapy for adjunct treatment of obsessive-compulsive disorder (OCD). Alpharetta-Ga.-based MagVenture said in a news release that the authorization is its second from the FDA, having already been cleared for its treatment of major depressive disorder. TMS Therapy uses magnetic pulses to stimulate a specific area […]
FDA clears Axilum Robotics’ system for TMS positioning
Strasbourg, France-based Axilum Robotics said today that it has received 510(k) clearance from FDA for its TMS-Cobot TS MV, indicated for the spatial positioning and orientation of the treatment coil of the MagVenture TMS Therapy system. Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique. Its approved and potential applications range from neuroscience research to the treatment of drug-resistant […]
FDA grants expanded clearance for MagVenture’s depression-treating TMS system
Non-invasive magnetic stimulation developer MagVenture said today it won expanded FDA clearance for its Transcranial Magnetic Stimulation system, now cleared for treatment protocols with shorter treatment sessions. The Atlanta-based company said a new treatment form using its TMS hardware, dubbed theta burst stimulation, can now be provided in three-minute sessions, down from previous treatment protocols which required […]
MagVenture wins FDA nod for entry-level MagVita TMS device
Non-invasive magnetic stimulation developer MagVenture said today it won FDA clearance for an entry-level version of its MagVita transcranial magnetic stimulation device designed for treating major depressive disorder. The Atlanta-based company said that the newly cleared device is designed specifically for smaller psychiatric practices looking to begin to provide TMS services but are unsure of […]
FDA clears MagVenture’s MagVita TMS
Non-invasive magnetic stimulation developer MagVenture said last month it won FDA 510(k) clearance for its MagVita transcranial magnetic stimulation therapy system. The device, which uses magnetic fields and electric currents to excite and depolarize neurons in the brain and nervous system, is indicated for treating major depressive disorder in patients non-receptive to antidepressant medication, the […]